Glenmark cuts price of COVID-19 drug favipiravir version to $1 per tablet - Reuters India

12:21am PDT - July 13th, 2020    symptoms of covid - Reuters

Glenmark Pharmaceuticals Ltd said on Monday it would lower the price of its generic version of favipiravir, FabiFlu, to 75 rupees ($0.9983) per tablet for restricted emergency use in patients with mild-to-moderate COVID-19 symptoms in India.